Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11551515 | PMC |
http://dx.doi.org/10.1016/j.vgie.2024.07.001 | DOI Listing |
World J Gastrointest Endosc
December 2024
Department of Emergency Medicine, General Hospital of Larissa, Larisa 41221, Greece.
The Baveno VII consensus, released in 2023, recommends that the endoscopic treatment of choice for managing bleeding gastric varices (GV) is endoscopic ultrasound (EUS)-guided treatment, specifically EUS-guided cyanoacrylate (CYA) glue injection. This approach has been endorsed due to its efficacy in controlling bleeding while reducing rebleeding rates, compared to other endoscopic techniques. Despite its efficacy, CYA injection for GV has been linked to rare but serious adverse events, such as glue embolization leading to pulmonary embolism, infection/bacteremia, splenic infarction, intra-procedural and post-procedural complications.
View Article and Find Full Text PDFVideoGIE
November 2024
Ansh Clinic, Ahmedabad, Gujarat, India.
Gastrointest Endosc
October 2024
Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Background And Aims: Gastric variceal bleeding occurs less commonly than bleeding from esophageal varices (EVs), although it is associated with higher morbidity and mortality. Bleeding from gastroesophageal varices type 1 (GOV1) is treated like EVs. In contrast, other forms of gastric variceal bleeding, including gastroesophageal varices type 2 (GOV2) and isolated gastric varices types 1 (IGV1) and 2 (IGV2), are treated with varying endoscopic approaches.
View Article and Find Full Text PDFGastrointest Endosc
October 2024
Department of Endoscopy, Barretos Cancer Hospital, Barretos, Brazil.
Indian J Gastroenterol
October 2024
Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226 014, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!